Regeneron Pharmaceuticals REGN
NASDAQ REGN
$904.35 +1.45 (+0.16%)
At close: Nov 6, 2026 · 4:00 PM EST

Regeneron Pharmaceuticals (REGN) Cost of Revenue (2009 - 2026)

Updated

Regeneron Pharmaceuticals' Cost of Revenue was $573.6 million in Q3 2026, up 10.0% from $521.6 million a year earlier but down 0.5% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Cost of Revenue (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Regeneron Pharmaceuticals' Cost of Revenue was $2.4 billion through Sep 30, 2026, up 15.5% year-over-year; for FY2025, it was $2.1 billion, up 6.6% from FY2024.

  • Cost of Revenue has now increased for three consecutive years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
  • In earlier years, Cost of Revenue was $1.97 billion in FY2024 (+8.5%), $1.82 billion in FY2023 (+16.4%), $1.56 billion in FY2022 (-36.0%) and $2.44 billion in FY2021 (+117.7%).
  • Quarterly Cost of Revenue has moved between $297.1 million (Q2 2022) and $982.6 million (Q4 2021) over five years.
  • Compared with a year earlier, Cost of Revenue has increased for ten straight quarters, with growth averaging 12.4% over the last eight quarters.
  • The best year-over-year quarter for Cost of Revenue over five years was Q4 2021 (growth of 178.3%); the worst was Q2 2022 (a decline of 57.2%).
  • Per Business Quant data, REGN's Cost of Revenue in the three quarters before Q3 2026 was $576.5 million (Q2 2026), $669.4 million (Q1 2026) and $584.6 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 3.93 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 8.10 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 4.29 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 4.89 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 2.95 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 2.79 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 1.57 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 4.03 Bn
10 Regeneron Pharmaceuticals 92.03 Bn 57.37 Bn 4.54 Bn 573.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 573.60 Mn
Jun 30, 2026 576.50 Mn
Mar 31, 2026 669.40 Mn
Dec 31, 2025 584.60 Mn
Sep 30, 2025 521.60 Mn
Jun 30, 2025 530.20 Mn
Mar 31, 2025 464.30 Mn
Dec 31, 2024 565.40 Mn
Sep 30, 2024 491.10 Mn
Jun 30, 2024 480.20 Mn
Mar 31, 2024 433.80 Mn
Dec 31, 2023 517.00 Mn
Sep 30, 2023 436.40 Mn
Jun 30, 2023 404.90 Mn
Mar 31, 2023 457.50 Mn
Dec 31, 2022 540.60 Mn
Sep 30, 2022 317.80 Mn
Jun 30, 2022 297.10 Mn
Mar 31, 2022 404.90 Mn
Dec 31, 2021 982.60 Mn
API Access

Regeneron Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=REGN&period=max&api_key=YOUR_API_KEY